Structural determinants for membrane binding of the EGFR juxtamembrane domain

Area of Science:

• Biochemistry
• Molecular Biology
• Cancer Research

Background:

• Overactivation of the epidermal growth factor receptor (EGFR) drives multiple cancers.
• The EGFR juxtamembrane domain (JM) interacts with the cell membrane, regulating kinase activity.
• The specific lipids recognized by EGFR-JM and the interaction details are not well understood.

Purpose of the Study:

• To elucidate the lipid recognition specificity of the EGFR-JM.
• To characterize the molecular details of the EGFR-JM and membrane interaction.
• To investigate the functional implications of membrane binding on EGFR activity.

Main Methods:

• Lipid strip and liposome pulldown assays were used to identify specific lipid interactions.
• NMR-titration-based chemical shift perturbation and paramagnetic relaxation enhancement analyses were employed to map the membrane-binding site.
• Bioinformatic analysis predicted the dimerization motif within the JM region.

Main Results:

• EGFR-JM specifically binds to membranes containing phosphatidylinositol 4,5-bisphosphate (PI(4,5)P2) or phosphatidylserine.
• The membrane-binding site was mapped to residues Isoleucine 649 to Leucine 659 (I649–L659) within the JM domain.
• This identified membrane-binding region overlaps with the predicted dimerization motif (⁶⁵⁵LRRLL⁶⁵⁹) of the JM domain.

Conclusions:

• EGFR-JM exhibits specific lipid recognition, interacting with PI(4,5)P2 and phosphatidylserine-containing membranes.
• Membrane binding to the JM domain, involving residues I649–L659, is demonstrated.
• The proximity of the membrane-binding site to the dimerization motif suggests that membrane interaction may regulate EGFR JM dimerization and subsequent kinase activation, offering a potential therapeutic target for EGFR-driven cancers.